[1] Ke C,Narayan KMV,Chan JCN,et al.Pathophysiology,phenotypes and management of type 2 diabetes mellitus in Indian and Chinese populations[J]. Nat Rev Endocrinol,2022 ,18(7):413-432.
[2] 《中国老年型糖尿病防治临床指南》编写组.中国老年2型糖尿病防治临床指南(2022年版)[J].中国糖尿病杂志,2022,30(1):2-51 .
[3] 魏成,王梦龙,徐瑶,等.1990—2019年中国人群2型糖尿病疾病负担及其危险因素分析[J].中国循证心血管医学杂志,2023,15(6):657-661,666.
[4] 王富军,王文琦.《中国2型糖尿病防治指南(2020年版)》解读[J].河北医科大学学报,2021,42(12):1365-1371.
[5] Wright WL,Urquhart S,Brunton S.Beyond blood glucose and blood pressure control in type 2 diabetes:Alternative management strategies to prevent the development and progression of CKD[J]. J Prim Care Community Health,2023,14(1-12):21501319231153599.
[6] Bour C,Ahne A,Aguayo G,et al.Global diabetes burden:Analysis of regional differences to improve diabetes care[J]. BMJ Open Diabetes Res Care,2022 ,10(5):e003040.
[7] 马婧,徐爱军. 四种基本医疗保险制度下高血压患者卫生服务利用状况研究[J].中国全科医学,2018,21(28):3518-3522.
[8] McRee B,Babor TF,Lynch ML,et al. Reliability and validity of a two-question version of the World Health Organization's alcohol,smoking and substance involvement screening test:The ASSIST-FC[J]. J Stud Alcohol Drugs,2018,79(4):649-657.
[9] Khan RMM,Chua ZJY,Tan JC,et al.From pre-diabetes to diabetes:Diagnosis,treatments and translational research[J]. Medicina (Kaunas),2019,55(9):546.
[10] 李巍巍. 中国血糖监测临床应用指南(2015年版)[J].解放军医药杂志,2015,27(11):117.
[11] 贾欣欣,胡红岩,王萱萱,等. 我国15岁及以上居民自评健康状况及其影响因素分析[J]. 中国卫生政策研究,2016,9(6):62-67.
[12] Wang Y,Hu XJ,Wang HHX,et al.Follow-up care delivery in community-based hypertension and type 2 diabetes management:A multi-centre,survey study among rural primary care physicians in China[J]. BMC Fam Pract,2021,22(1):224.
[13] Hu ZD,Zhang KP,Huang Y,et al.Compliance to self-monitoring of blood glucose among patients with type 2 diabetes mellitus and its influential factors:A real-world cross-sectional study based on the Tencent TDF-I blood glucose monitoring platform[J]. Mhealth,2017,3(6):25.
[14] 郑兰芳,曹悌鸿.2型糖尿病患者自我血糖监测现状调查及其影响因素[J].中国卫生工程学,2022,21(6):953-955,958.
[15] Liu J,Shi X,Guo B.Influence of information-based continuous care on disease control and treatment compliance of elderly diabetic patients[J]. Evid Based Complement Alternat Med,2022,2022(10):4023123.
[16] Peng X,Guo X,Li H,et al.A Qualitative exploration of self-management behaviors and influencing factors in patients with type 2 diabetes[J]. Front Endocrinol (Lausanne),2022,13(2):771293.
[17] Lu R,Li Y,Zheng Z,et al.Exploring factors associated with self-management compliance among rural elders with diabetes[J]. Inquiry,2021,58(1-12):469580211012491.
[18] Lavernia F,Adkins SE,Shubrook JH.Use of oral combination therapy for type 2 diabetes in primary care:Meeting individualized patient goals[J]. Postgrad Med,2015,127(8):808-817. |
